Randomized Phase II trial assessing estramustine and vinblastine combination chemotherapy vs estramustine alone in patients with progressive hormone-escaped metastatic prostate cancer

Based on the results of combined data from three North American Phase II studies, a randomised Phase II study in the same patient population was performed, using combination chemotherapy with estramustine phosphate (EMP) and vinblastine (VBL) in hormone refractory prostate cancer patients. In all, 9...

Descripción completa

Detalles Bibliográficos
Autores principales: Albrecht, W, Van Poppel, H, Horenblas, S, Mickisch, G, Horwich, A, Serretta, V, Casetta, G, Maréchal, J M, Jones, W G, Kalman, S, Sylvester, R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395315/
https://www.ncbi.nlm.nih.gov/pubmed/14710214
http://dx.doi.org/10.1038/sj.bjc.6601468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2395315/
https://www.ncbi.nlm.nih.gov/pubmed/14710214
http://dx.doi.org/10.1038/sj.bjc.6601468

Ejemplares similares